Julia Knafo

Associate

Julia Knafo

Julia Knafo

Associate

Expertise
Bar Admissions
  • Québec, 2019

Julia is developing a diverse corporate practice.

She has assisted clients on a variety of transactions, including private and public mergers and acquisitions, commercial real estate and other corporate matters.

Julia Knafo

Associate

Julia is developing a diverse corporate practice.

She has assisted clients on a variety of transactions, including private and public mergers and acquisitions, commercial real estate and other corporate matters.

Teneo

Acted for Teneo in its acquisition of Hatley Strategy Advisors, a leading strategic communications and corporate advisory firm based in Montréal, Canada.

Novacap Management Inc.

Acting for Novacap Management Inc. in the formation and fundraising of Novacap Financial Services I a $500-million private equity fund which invests in the financial services sector.

Novacap Management Inc.

Acted for Novacap Management Inc. in its fundraising and equity raise for Nuvei, a leading global payment technology provider valued at US$2 billion. The equity financing raised US$270 million with investments from several major Canadian institutional investors.

Knight Therapeutics Inc.

Acting for Knight Therapeutics Inc. in its transformative acquisition of all of the issued and outstanding shares of Biotoscana Investments S.A. (GBT), a Luxembourg company listed on the Brazilian stock exchange, for an expected aggregate purchase price of $369 million.

Knight Therapeutics Inc.

Acting for Knight Therapeutics Inc. in its transformative acquisition of all of the issued and outstanding shares of Biotoscana Investments S.A. (GBT), a Luxembourg company listed on the Brazilian stock exchange, for an expected aggregate purchase price of $369 million. GBT is a leading pharmaceutical group operating in 10 countries in Latin America, with a focus on oncology, onco-hematology, infectious diseases and other specialty therapeutic areas. To complete the transaction, Knight will first acquire a 51.21% interest in GBT from its majority shareholders, which include private equity firm Advent International and health investor Essex Woodlands, for approximately $189 million. Immediately after the closing of the first transaction, Knight will launch a mandatory tender offer to acquire the remaining 48.79% interest in GBT from public shareholders on similar terms, for expected cash consideration of approximately $180 million.

Université de Montréal—Léonard Ovide Hétu Award (2017); Bohémier-Ferland Award (2018)

Bar Admissions

Québec, 2019

Education

Université de Montréal, JD, 2018
Université de Montréal, BCL/LLB (Dean’s Honours’ List), 2017

Julia is developing a diverse corporate practice.

She has assisted clients on a variety of transactions, including private and public mergers and acquisitions, commercial real estate and other corporate matters.

Teneo

Acted for Teneo in its acquisition of Hatley Strategy Advisors, a leading strategic communications and corporate advisory firm based in Montréal, Canada.

Novacap Management Inc.

Acting for Novacap Management Inc. in the formation and fundraising of Novacap Financial Services I a $500-million private equity fund which invests in the financial services sector.

Novacap Management Inc.

Acted for Novacap Management Inc. in its fundraising and equity raise for Nuvei, a leading global payment technology provider valued at US$2 billion. The equity financing raised US$270 million with investments from several major Canadian institutional investors.

Knight Therapeutics Inc.

Acting for Knight Therapeutics Inc. in its transformative acquisition of all of the issued and outstanding shares of Biotoscana Investments S.A. (GBT), a Luxembourg company listed on the Brazilian stock exchange, for an expected aggregate purchase price of $369 million.

Knight Therapeutics Inc.

Acting for Knight Therapeutics Inc. in its transformative acquisition of all of the issued and outstanding shares of Biotoscana Investments S.A. (GBT), a Luxembourg company listed on the Brazilian stock exchange, for an expected aggregate purchase price of $369 million. GBT is a leading pharmaceutical group operating in 10 countries in Latin America, with a focus on oncology, onco-hematology, infectious diseases and other specialty therapeutic areas. To complete the transaction, Knight will first acquire a 51.21% interest in GBT from its majority shareholders, which include private equity firm Advent International and health investor Essex Woodlands, for approximately $189 million. Immediately after the closing of the first transaction, Knight will launch a mandatory tender offer to acquire the remaining 48.79% interest in GBT from public shareholders on similar terms, for expected cash consideration of approximately $180 million.

Université de Montréal—Léonard Ovide Hétu Award (2017); Bohémier-Ferland Award (2018)

Bar Admissions

Québec, 2019

Education

Université de Montréal, JD, 2018
Université de Montréal, BCL/LLB (Dean’s Honours’ List), 2017